# Animal-Based and Carnivore Contraindications: Who Should Not Follow Influencer Protocols

> Highest concern: FH/ASCVD, pregnancy/infants, immunocompromise, CKD, gout, hemochromatosis, active eating disorders. List stop rules—not just macros.

*Published 2026-07-10 · Updated 2026-07-10 · By Marcus Chen*

In short

Contraindication box first: **FH/ASCVD**, **pregnancy/infants**, immunocompromise, **CKD**, gout, **hemochromatosis**, active ED. Animal-based is not risk-free simplification.

Protocol calculators sell universality. Physiology does not. Before meat-and-fruit maximalism becomes identity, map the groups for whom the experiment is relatively or absolutely the wrong tool.

*This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.*

## Which cardiovascular phenotypes need specialist plans?

FH, prior events, and extreme baseline ApoB change the risk calculus of SFA-heavy patterns.

LMHR-style lean high-LDL presentations still need longitudinal risk assessment—not meme reassurance from triglycerides alone.

AHA-class dietary fat guidance remains the default comparator until animal-based event trials exist.

## What food-safety lines are non-negotiable?

Unpasteurized milk and high-risk raw animal products: FDA pathogen warnings apply regardless of ancestral branding.

Immunocompromised and elderly hosts amplify foodborne severity.

Pregnancy: limit liver retinol; no raw dairy; ensure folate/iodine adequacy with clinical prenatal standards.

  Key reference points
  PopulationPrimary riskAction

    FH / ASCVDApoB riseSpecialist plan first
    Pregnancy / infantsPathogens + retinolNo raw dairy; limit liver
    CKDProtein loadNephrology guidance
    GoutPurine organsAvoid triggers
    HemochromatosisIron/liverFerritin strategy
    ED historyRigidity/purityMD + RD care

## Which metabolic and organ-system caveats matter?

CKD protein ceilings; gout purines from organs; iron overload from heme/liver frequency.

Calcium oxalate stone formers need individualized 24-hour urine logic—not internet oxalate folklore alone.

Major diet shifts can interact with weight, hydration, and medications—notify prescribers.

## How should healthy adults still monitor?

Even without classic contraindications, elimination diets deserve baseline and follow-up labs.

Psychological rigidity and purity culture are clinical risk factors, not personality flexes.

Prefer time-limited experiments with exit criteria over lifelong identity lock-in.

Sources: [FDA raw milk dangers](https://www.fda.gov/food/buy-store-serve-safe-food/dangers-raw-milk-unpasteurized-milk-can-pose-serious-health-risk); [Lennerz survey lipids context](https://pubmed.ncbi.nlm.nih.gov/34934897/); [AHA dietary fats 2017](https://www.ahajournals.org/doi/10.1161/cir.0000000000000510).

Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

## Sources

1. [FDA raw milk dangers](https://www.fda.gov/food/buy-store-serve-safe-food/dangers-raw-milk-unpasteurized-milk-can-pose-serious-health-risk)
2. [Lennerz survey lipids context](https://pubmed.ncbi.nlm.nih.gov/34934897/)
3. [AHA dietary fats 2017](https://www.ahajournals.org/doi/10.1161/cir.0000000000000510)

---
Source: https://healthcanon.com/expert-dossiers/paul-saladino-contraindications
Index: https://healthcanon.com/llms.txt · Full text: https://healthcanon.com/llms-full.txt
